Skip to search formSkip to main contentSkip to account menu

Capromab Pendetide

Known as: 7E11-C5.3-GYK-DTPA 
An immunoconjugate of the murine monoclonal antibody, 7E11-C5.3 (Capromab), conjugated to the linker-chelator, glycyl-tyrosyl-(N… 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

CapromabIndicators and ReagentsMonoclonal Antibodies

Narrower (3)

Cytogen 356Indium-111-CYT-356Prostascint

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
FACBC Positron Emission Tomography-Computerized Tomography and 111 In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma…
Accepted for publication October 17, 2013. Study received Emory University institutional review board approval. Supported by… 
2013
2013
Improved performance of SPECT-CT In-111 capromab pendetide by correlation with diffusion-weighted magnetic resonance imaging for identifying metastatic pelvic lymphadenopathy in prostate cancer
PurposeTo preliminarily evaluate the potential for an improvement in diagnostic performance by a combined interpretation of In… 
Review
2012
Review
2012
Combined SPECT and Multidetector CT for Prostate Cancer Evaluations.
(111)In-capromab pendetide is an imaging probe for noninvasive detection of prostate cancer dissemination, and can be difficult… 
Review
2011
Review
2011
Diagnostic Performance of In-111 Capromab Pendetide SPECT/CT in Localized and Metastatic Prostate Cancer
Purpose: To determine the diagnostic performance of In-111 capromab pendetide single photon emission computed tomography/computed… 
2006
2006
Corrective 111 In Capromab Pendetide SPECT Image Reconstruction Methods for Improved Detection of Recurrent Prostate Cancer
Abstract : It is generally recognized that (111)In capromab pendetide (PS) scans are technically challenging to perform and… 
Review
2004
Review
2004
Role of ProstaScint® for brachytherapy in localized prostate adenocarcinoma
ProstaScint® (CYT-356 or capromab pendetide, Cytogen) is an 111In-labeled monoclonal mouse antibody specific for prostate… 
2000
2000
111In-Capromab Pendetide
Each year, approximately 210 000 American men are diagnosed with prostate cancer and 41 800 die from the disease — numbers… 
1999
1999
Indium-111 capromab pendetide (ProstaScint) images before and after salvage radiation therapy.
A 50-year-old man diagnosed with early-stage prostate cancer underwent a radical prostatectomy in 1992. His prostate-specific… 
1999
1999
111Indium-capromab pendetide unexpectedly localizes to renal cell carcinoma.
1998
1998
Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging.
OBJECTIVE A dual-isotope imaging protocol using 99mTc-labeled red blood cells with 111In capromab pendetide monoclonal antibody… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)